Century Therapeutics (IPSC) Interest Expenses (2020 - 2023)

Century Therapeutics (IPSC) has 4 years of Interest Expenses data on file, last reported at $136000.0 in Q2 2023.

• Interest Expenses for Q2 2023 came in at $136000.0, down 58.79% year-over-year; the trailing twelve-month figure through Mar 2024 was $136000.0 (down 91.59% YoY), and the FY2023 annual result was $540000.0, down 62.24% from the prior year.
• Interest Expenses declined to $136000.0 in Q2 2023 per IPSC's latest filing, from $348000.0 in the prior quarter.
• Over five years, Interest Expenses peaked at $643000.0 in Q4 2022 and troughed at $45000.0 in Q3 2020.
• A 4-year average of $310250.0 and a median of $319500.0 in 2021 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2021 and 2023: Interest Expenses jumped 615.56% in 2021, then plunged 58.79% in 2023.
• A 4-year view of Interest Expenses shows it stood at $336000.0 in 2020, then decreased by 4.46% to $321000.0 in 2021, then jumped by 100.31% to $643000.0 in 2022, then sank by 78.85% to $136000.0 in 2023.
• Business Quant data shows IPSC's Interest Expenses at $136000.0 in Q2 2023, $348000.0 in Q1 2023, and $643000.0 in Q4 2022.